I Peter

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. pmc Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA
    Obesity (Silver Spring) 20:1675-82. 2012
  2. pmc ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial
    Melissa C Smart-Halajko
    Division of Cardiovascular Genetics, British Heart Foundation Laboratories, Department of Medicine, Royal Free and UCL Medical School, London, UK
    BMC Med Genet 12:89. 2011
  3. pmc Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice
    Yingli Wang
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York, USA
    BMC Dev Biol 10:22. 2010
  4. pmc Association between arterial stiffness and variations in oestrogen-related genes
    I Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine of New York University, New York, NY 10029, USA
    J Hum Hypertens 23:636-44. 2009
  5. pmc Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis
    I Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York 10029, USA
    Osteoporos Int 22:1199-209. 2011
  6. pmc Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029 USA
    BMC Med Genet 12:63. 2011
  7. pmc Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes
    S Martis
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
    Pharmacogenomics J 13:369-77. 2013
  8. doi request reprint Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial
    K L Ellis
    Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    Pharmacogenomics J 15:55-62. 2015
  9. pmc Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness
    S A Scott
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
    Pharmacogenomics J 12:297-305. 2012

Collaborators

Detail Information

Publications9

  1. pmc Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA
    Obesity (Silver Spring) 20:1675-82. 2012
    ....
  2. pmc ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial
    Melissa C Smart-Halajko
    Division of Cardiovascular Genetics, British Heart Foundation Laboratories, Department of Medicine, Royal Free and UCL Medical School, London, UK
    BMC Med Genet 12:89. 2011
    ....
  3. pmc Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice
    Yingli Wang
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York, USA
    BMC Dev Biol 10:22. 2010
    ..We previously reported an inbred transgenic mouse model with the Fgfr2 +/S252W mutation on the C57BL/6J background for Apert syndrome. Here we present a mouse model for the Fgfr2+/P253R mutation...
  4. pmc Association between arterial stiffness and variations in oestrogen-related genes
    I Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine of New York University, New York, NY 10029, USA
    J Hum Hypertens 23:636-44. 2009
    ..Our findings will need to be replicated in additional cohorts...
  5. pmc Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis
    I Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York 10029, USA
    Osteoporos Int 22:1199-209. 2011
    ..Despite lower trochanteric and lumbar BMD in APOE4 carriers, there is insufficient evidence to support a consistent association of APOE with bone health...
  6. pmc Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029 USA
    BMC Med Genet 12:63. 2011
    ..We evaluated a set of well-established CD-susceptibility variants to determine if they can explain the increased CD risk in the AJ population...
  7. pmc Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes
    S Martis
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
    Pharmacogenomics J 13:369-77. 2013
    ..These results have important implications for pharmacogenomic association studies involving the CYP2C locus and are clinically relevant when administering CYP2C-substrate medications. ..
  8. doi request reprint Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial
    K L Ellis
    Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    Pharmacogenomics J 15:55-62. 2015
    ..These studies identify genetic factors that may impact the metabolic response to GIK, which could influence treatment benefits in the setting of acute coronary syndromes (ACS). ..
  9. pmc Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness
    S A Scott
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
    Pharmacogenomics J 12:297-305. 2012
    ..Combining CYP2C19 and ABCB1 identified ∼1 in 3 AJ and ∼1 in 2 SJ individuals at increased risk for adverse responses to clopidogrel. These data underscore the importance of including *4B and *17 when clinically genotyping CYP2C19...